betamethasone valerate on post-cryotherapy

Phase 2

Recruiting

Conditions: skin wart.
Viral warts

Registration Number: IRCT20170818035762N3

Lead Sponsor: Mazandaran University of Medical Sciences

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Recruiting

Sex: All

Target Recruitment: 40

Inclusion Criteria

Patients with skin wart who are diagnosed by a dermatologist clinically or pathologically and have cryotherapy indications.
Patients over 2 years of age
They have a conscious consent to enter the study
the maximum number of warts is up to 20

Exclusion Criteria

pregnant and lactating women
People treated with systemic medications that interfere with wound healing or immuno suppressive drugs
Patients who have contraindications for cryotherapy
Patients who have used topical medications other than emollients in the past month
People who are allergic to betamethasone or topical steroids
Patients with wound healing disorders such as diabetes
Distributed and resistant warts that need further treatment

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Tolerance of pain to cryotherapy treatment. Timepoint: Day 1,7 and 14. Method of measurement: Vas scale.

Secondary Outcome Measures

Name	Time	Method
Illness severity. Timepoint: At the beginning of the study. Method of measurement: Based on the number of warts.;Duration of illness. Timepoint: At the beginning of the study. Method of measurement: Number of days before starting treatment.;Eritrea. Timepoint: The second, eighth and fifteenth day after starting treatment. Method of measurement: Based on the examination.;Blisters. Timepoint: The second, eighth and fifteenth day after starting treatment. Method of measurement: Based on the examination.;Scar. Timepoint: The second, eighth and fifteenth day after starting treatment. Method of measurement: Based on the examination.